HK1036401A1 - Orally disintegrable tablets comprising a benzimidazole - Google Patents
Orally disintegrable tablets comprising a benzimidazoleInfo
- Publication number
- HK1036401A1 HK1036401A1 HK01106717A HK01106717A HK1036401A1 HK 1036401 A1 HK1036401 A1 HK 1036401A1 HK 01106717 A HK01106717 A HK 01106717A HK 01106717 A HK01106717 A HK 01106717A HK 1036401 A1 HK1036401 A1 HK 1036401A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- administered
- orally disintegrable
- fine granules
- average particle
- particle diameter
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13547298 | 1998-05-18 | ||
JP21926698 | 1998-08-03 | ||
JP22215198 | 1998-08-05 | ||
JP514499 | 1999-01-12 | ||
JP1585199 | 1999-01-25 | ||
PCT/JP1999/002548 WO1999059544A2 (en) | 1998-05-18 | 1999-05-17 | Orally disintegrable tablets |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1036401A1 true HK1036401A1 (en) | 2002-01-04 |
Family
ID=27518561
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01106717A HK1036401A1 (en) | 1998-05-18 | 2001-09-22 | Orally disintegrable tablets comprising a benzimidazole |
HK07102071.1A HK1096021A1 (zh) | 1998-05-18 | 2001-09-22 | 可崩解的口服片劑 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07102071.1A HK1096021A1 (zh) | 1998-05-18 | 2001-09-22 | 可崩解的口服片劑 |
Country Status (16)
Country | Link |
---|---|
US (5) | US6328994B1 (zh) |
EP (3) | EP2263660B1 (zh) |
JP (2) | JP3746167B2 (zh) |
KR (2) | KR100554924B1 (zh) |
CN (1) | CN1195500C (zh) |
AT (1) | ATE348601T1 (zh) |
AU (1) | AU3731699A (zh) |
CA (2) | CA2587022A1 (zh) |
CY (2) | CY1105908T1 (zh) |
DE (1) | DE69934505T2 (zh) |
DK (3) | DK1736144T3 (zh) |
ES (2) | ES2559766T3 (zh) |
HK (2) | HK1036401A1 (zh) |
PT (3) | PT2263660T (zh) |
TW (1) | TWI243062B (zh) |
WO (1) | WO1999059544A2 (zh) |
Families Citing this family (220)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
EP2263660B1 (en) | 1998-05-18 | 2017-09-27 | Takeda Pharmaceutical Company Limited | Orally disintegrable tablets |
US20060182802A1 (en) * | 1998-07-28 | 2006-08-17 | Toshihiro Shimizu | Rapidly disintegrable solid preparation |
CA2374760A1 (en) * | 1999-06-18 | 2000-12-28 | Takeda Chemical Industries, Ltd. | Quickly disintegrating solid preparations |
JP2001058944A (ja) * | 1999-06-18 | 2001-03-06 | Takeda Chem Ind Ltd | 速崩壊性固形製剤 |
US20060034937A1 (en) * | 1999-11-23 | 2006-02-16 | Mahesh Patel | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
WO2001064189A1 (fr) * | 2000-03-02 | 2001-09-07 | Basf Aktiengesellschaft | Granules revetus et compositions moussantes les contenant |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
US20030185886A1 (en) * | 2000-05-26 | 2003-10-02 | Hanmi Pharm. Co., Ltd. | Process for the preparation of rapidly disintegrating tablet |
RU2203042C2 (ru) * | 2000-11-28 | 2003-04-27 | Комиссарова Ирина Алексеевна | Фармацевтическая композиция и способ ее получения |
SI1341528T1 (sl) * | 2000-12-07 | 2012-05-31 | Nycomed Gmbh | Hitro razpadljiva tableta ki obsega kislinsko labilno aktivno sestavino |
US20020192299A1 (en) * | 2000-12-28 | 2002-12-19 | Rajneesh Taneja | Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
WO2002060446A1 (en) * | 2001-01-29 | 2002-08-08 | Shionogi & Co., Ltd. | Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
MXPA03007283A (es) * | 2001-02-15 | 2003-12-04 | Tanabe Seiyaku Co | Tabletas que se desintegran rapidamente en la cavidad oral. |
JP2004520420A (ja) * | 2001-03-05 | 2004-07-08 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 味が遮蔽された製薬学的組成物 |
CA2440361A1 (en) * | 2001-03-06 | 2002-09-12 | Kyowa Hakko Kogyo Co. Ltd. | Intraorally rapidly disintegrable preparation |
US20040121006A1 (en) * | 2001-03-06 | 2004-06-24 | Shoichi Narita | Utilization of spray-dried powder containing sugar alcohol |
DK1405621T3 (da) * | 2001-06-20 | 2011-07-18 | Takeda Pharmaceutical | Fremgangsmåde til fremstilling af tablet |
JP5138856B2 (ja) * | 2001-06-20 | 2013-02-06 | 武田薬品工業株式会社 | 錠剤の製造方法 |
US20040219211A1 (en) * | 2001-07-16 | 2004-11-04 | Bruno Criere | Pharmeceutical formulation comprising a proton pump inhibitor and antacids |
WO2003020241A2 (en) * | 2001-09-05 | 2003-03-13 | Vectura Limited | Functional powders for oral delivery |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
CN100562317C (zh) * | 2001-10-17 | 2009-11-25 | 武田药品工业株式会社 | 含大量酸不稳定药物的颗粒 |
JP2006282677A (ja) * | 2001-10-17 | 2006-10-19 | Takeda Chem Ind Ltd | 酸に不安定な薬物の高含量顆粒 |
JP4331930B2 (ja) * | 2001-10-17 | 2009-09-16 | 武田薬品工業株式会社 | 酸に不安定な薬物の高含量顆粒 |
US20030190359A1 (en) * | 2001-10-29 | 2003-10-09 | Franz G. Andrew | Levothyroxine compositions having unique triiodothyronine Tmax properties |
US20050163846A1 (en) * | 2001-11-21 | 2005-07-28 | Eisai Co., Ltd. | Preparation composition containing acid-unstable physiologically active compound, and process for producing same |
WO2003043661A1 (fr) * | 2001-11-21 | 2003-05-30 | Eisai Co., Ltd. | Compositions de preparation contenant des composes actifs au plan physiologiques et instables aux acides et leur procede de production |
JP4833464B2 (ja) * | 2001-11-28 | 2011-12-07 | 大正製薬株式会社 | 難溶性薬物含有固形製剤の製造方法 |
WO2003074085A1 (fr) * | 2002-03-06 | 2003-09-12 | Kyowa Hakko Kogyo Co., Ltd. | Comprimes a desintegration rapide dans la cavite buccale |
US6572889B1 (en) * | 2002-03-07 | 2003-06-03 | Noveon Ip Holdings Corp. | Controlled release solid dosage carbamazepine formulations |
EP1490031A1 (en) * | 2002-03-07 | 2004-12-29 | Vectura Limited | Fast melt multiparticulate formulations for oral delivery |
US20040082618A1 (en) * | 2002-07-03 | 2004-04-29 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
US20040005362A1 (en) * | 2002-07-03 | 2004-01-08 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
JP4169329B2 (ja) * | 2002-10-04 | 2008-10-22 | 村樫石灰工業株式会社 | 消石灰系塗材組成物 |
EP2596792A1 (en) * | 2002-10-16 | 2013-05-29 | Takeda Pharmaceutical Company Limited | Stable solid preparations |
MY148805A (en) * | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
FR2845915B1 (fr) * | 2002-10-21 | 2006-06-23 | Negma Gild | Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien |
US20070243251A1 (en) * | 2002-12-20 | 2007-10-18 | Rajneesh Taneja | Dosage Forms Containing A PPI, NSAID, and Buffer |
US20040121004A1 (en) * | 2002-12-20 | 2004-06-24 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
US20040208931A1 (en) * | 2002-12-30 | 2004-10-21 | Friend David R | Fast dissolving films for oral administration of drugs |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
US20040166162A1 (en) * | 2003-01-24 | 2004-08-26 | Robert Niecestro | Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
US20040156894A1 (en) * | 2003-02-07 | 2004-08-12 | Grother Leon Paul | Use of edible acids in fast-dispersing pharmaceutical solid dosage forms |
US20050220870A1 (en) * | 2003-02-20 | 2005-10-06 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
WO2004075881A1 (en) * | 2003-02-28 | 2004-09-10 | Ranbaxy Laboratories Limited | Stable pharmaceutical composition of rabeprazole and processes for their preparation |
EP1602362B1 (en) * | 2003-03-12 | 2016-09-28 | Takeda Pharmaceutical Company Limited | Drug composition having active ingredient adhered at high concentration to spherical core |
US20040265375A1 (en) * | 2003-04-16 | 2004-12-30 | Platteeuw Johannes J. | Orally disintegrating tablets |
MXPA06000529A (es) * | 2003-07-18 | 2006-08-11 | Santarus Inc | Formulaciones farmaceuticas utiles para inhibir la secrecion de acido y metodos para elaborarlas y utilizarlas. |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US7838029B1 (en) * | 2003-07-31 | 2010-11-23 | Watson Laboratories, Inc. | Mirtazapine solid dosage forms |
FR2858556B1 (fr) * | 2003-08-06 | 2006-03-10 | Galenix Innovations | Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation |
US7390503B1 (en) | 2003-08-22 | 2008-06-24 | Barr Laboratories, Inc. | Ondansetron orally disintegrating tablets |
EP1696889A1 (en) * | 2003-08-28 | 2006-09-06 | Ranbaxy Laboratories, Ltd. | Pharmaceutical compositions of benzimidazole and processes for their preparation |
GB0320522D0 (en) * | 2003-09-02 | 2003-10-01 | Glaxo Group Ltd | Formulation |
AU2004285284B2 (en) * | 2003-10-31 | 2010-03-25 | Hexal Ag | A process for the preparation of an active-ingredient-containing formulation with a coating |
WO2005076987A2 (en) * | 2004-02-10 | 2005-08-25 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent |
CN1938026A (zh) * | 2004-03-26 | 2007-03-28 | 卫材R&D管理有限公司 | 控释制剂及其制造方法 |
EP1742630A4 (en) * | 2004-04-16 | 2010-01-20 | Santarus Inc | COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND PROKINETIC AGENT |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
KR20050118775A (ko) * | 2004-06-15 | 2005-12-20 | 주식회사 태평양 | 당류의 재결정화 및 약물과의 가교형성을 이용한 구강내속붕해정 |
US20060051421A1 (en) * | 2004-06-15 | 2006-03-09 | Nava Shterman | Stable pharmaceutical formulations of benzimidazole compounds |
AU2005264864B2 (en) | 2004-06-16 | 2011-08-11 | Takeda Pharmaceutical Company Limited | Multiple PPI dosage form |
EP1621187A1 (en) * | 2004-07-26 | 2006-02-01 | AstraZeneca AB | Pharmaceutical multiparticulate tablet formulations and process for their preparation |
JP4691925B2 (ja) * | 2004-08-05 | 2011-06-01 | 田辺三菱製薬株式会社 | 圧縮成型製剤の製造方法 |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US8758814B2 (en) | 2004-10-08 | 2014-06-24 | Mcneil-Ppc, Inc. | Chewable enteric coated aspirin tablets |
US8057820B2 (en) * | 2004-10-08 | 2011-11-15 | Mcneil-Ppc, Inc. | Enteric coated aspirin granules comingled with binder |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
WO2006047493A2 (en) | 2004-10-21 | 2006-05-04 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
CN100393304C (zh) * | 2005-02-28 | 2008-06-11 | 上海艾力斯医药科技有限公司 | 一种包含酸不稳定药物的微细颗粒及其制剂 |
IS7724A (is) | 2005-03-02 | 2006-09-03 | Actavis Group | Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat |
US20060210637A1 (en) * | 2005-03-17 | 2006-09-21 | Qpharma, Llc | Stable tablet dosage forms of proton pump inhibitors |
DE102005014248A1 (de) * | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
US20070026071A1 (en) * | 2005-07-28 | 2007-02-01 | Qpharma, Llc | Magnesium salt proton pump inhibitor dosage forms |
US20090148519A1 (en) * | 2005-09-29 | 2009-06-11 | Yasuhiro Zaima | Pulsed-release preparation having improved disintegration properties in vivo |
CN101309917B (zh) * | 2005-10-06 | 2013-09-11 | 奥斯拜客斯制药有限公司 | 具有增强治疗性质的胃h+,k+-atp酶氘代抑制剂 |
CN101340884A (zh) | 2005-10-19 | 2009-01-07 | 曼尼·马纳舍·辛格尔 | 用于治疗多汗症的方法 |
CN100431526C (zh) * | 2005-11-07 | 2008-11-12 | 上海艾力斯医药科技有限公司 | 一种酸敏感型药物的快速崩解片剂 |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US7811604B1 (en) | 2005-11-14 | 2010-10-12 | Barr Laboratories, Inc. | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same |
EP1962844A2 (en) * | 2005-12-20 | 2008-09-03 | Teva Pharmaceutical Industries Ltd | Lansoprazole orally disintegrating tablets |
CN101340897A (zh) * | 2005-12-20 | 2009-01-07 | 特瓦制药工业有限公司 | 兰索拉唑口腔崩解片剂 |
EP1813275A1 (en) * | 2005-12-20 | 2007-08-01 | Teva Pharmaceutical Industries Ltd | Lansoprazole orally disintegrating tablets |
US20070141151A1 (en) * | 2005-12-20 | 2007-06-21 | Silver David I | Lansoprazole orally disintegrating tablets |
CA2634969A1 (en) | 2005-12-28 | 2007-07-05 | Takeda Pharmaceutical Company Limited | Controlled release solid preparation |
CA2634232C (en) * | 2005-12-28 | 2013-08-20 | Takeda Pharmaceutical Company Limited | Method of producing solid preparation disintegrating in the oral cavity |
BRPI0620788A2 (pt) * | 2005-12-28 | 2011-11-22 | Takeda Pharmaceutical | preparação sólida |
JP3884056B1 (ja) * | 2006-01-27 | 2007-02-21 | 秋山錠剤株式会社 | 口腔内速崩錠の製造方法 |
EP1998762B1 (en) * | 2006-03-16 | 2010-11-03 | Novartis AG | Solid dosage form containing a taste masked active agent |
US20090208576A1 (en) * | 2006-03-31 | 2009-08-20 | Gandhi Anilkumar S | Orally Disintegrating Tablets |
EP2012756A4 (en) * | 2006-04-20 | 2013-01-23 | Inventia Healthcare Private Ltd | MULTI-UNIT COMPOSITIONS |
CA2654402A1 (en) * | 2006-06-01 | 2007-12-06 | Adel Penhasi | Multiple unit pharmaceutical formulation |
JP5141115B2 (ja) * | 2006-07-11 | 2013-02-13 | 大正製薬株式会社 | 不快味を呈する薬物含有製剤粒子 |
JP5160423B2 (ja) | 2006-07-19 | 2013-03-13 | 旭化成ケミカルズ株式会社 | 水易溶性薬物含有球状素顆粒の製造方法 |
JP5271081B2 (ja) * | 2006-07-26 | 2013-08-21 | 旭化成ケミカルズ株式会社 | 球形素顆粒およびその製造方法 |
US20080031944A1 (en) * | 2006-08-04 | 2008-02-07 | Cima Labs Inc. | Stabilization of lorazepam |
CN102813635A (zh) * | 2006-08-10 | 2012-12-12 | 武田药品工业株式会社 | 药物组合物 |
CN101516403B (zh) * | 2006-09-14 | 2013-10-02 | 安斯泰来制药株式会社 | 口腔崩解片及其制备方法 |
CA2665226C (en) | 2006-10-05 | 2014-05-13 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
US20100105738A1 (en) * | 2006-10-06 | 2010-04-29 | Mitsuru Mizuno | Extended release formulations of a proton pump inhibitor |
MX2009004475A (es) | 2006-10-27 | 2009-08-12 | Univ Missouri | Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma. |
US8668703B2 (en) * | 2006-12-01 | 2014-03-11 | Wake Forest University Health Sciences | Medical devices incorporating collagen inhibitors |
US8362088B2 (en) * | 2006-12-14 | 2013-01-29 | Warnock W Matthew | Method and article of manufacture for encapsulating a homeopathic ingredient with a second ingredient |
WO2008079342A2 (en) * | 2006-12-21 | 2008-07-03 | Mallinckrodt Inc. | Composition of and method for preparing orally disintegrating tablets |
US9486446B2 (en) | 2006-12-28 | 2016-11-08 | Takeda Pharmaceutical Company Limited | Orally disintegrating solid preparation |
JP3967767B1 (ja) * | 2007-02-08 | 2007-08-29 | 秋山錠剤株式会社 | 口腔内速崩錠の製造方法 |
US20080194307A1 (en) * | 2007-02-13 | 2008-08-14 | Jeff Sanger | Sports-based game of chance |
TWI405574B (zh) * | 2007-06-21 | 2013-08-21 | Otsuka Pharma Co Ltd | 藥學固體製劑及其製造方法 |
KR101436516B1 (ko) * | 2007-07-23 | 2014-09-02 | 주식회사태평양제약 | 코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법 |
WO2009034558A2 (en) | 2007-09-14 | 2009-03-19 | Wockhardt Research Centre | Rhein or diacerein compositions |
EP2044943A1 (en) * | 2007-10-04 | 2009-04-08 | Solvay Pharmaceuticals, Inc. | Pharmaceutical compositions comprising esterified estrogens and methyltestosterone and method of using the same |
EP2044929A1 (en) * | 2007-10-04 | 2009-04-08 | Laboratorios del Dr. Esteve S.A. | Oral fast distintegrating tablets |
EP2044932A1 (en) * | 2007-10-04 | 2009-04-08 | Laboratorios del Dr. Esteve S.A. | Mechanical protective layer for solid dosage forms |
MX2010003917A (es) | 2007-10-12 | 2012-09-28 | Takeda Pharmaceuticals Usa Inc | Metodos de tratamiento de trastornos gastrointestinales independientemente de la ingesta alimenticia. |
ES2633449T3 (es) | 2007-10-31 | 2017-09-21 | Johnson & Johnson Consumer Inc. | Forma de dosis oralmente desintegrable |
WO2009063916A1 (ja) * | 2007-11-16 | 2009-05-22 | Asahi Kasei Chemicals Corporation | 水系フィルムコーティング液、および、フィルムコーティング顆粒、ならびに、これを用いた錠剤 |
CN101878041A (zh) * | 2007-11-27 | 2010-11-03 | 大原药品工业株式会社 | 颗粒制剂的制造方法 |
BRPI0821761A2 (pt) * | 2007-12-21 | 2015-06-16 | Eurand Inc | Composições de comprimidos de desintegração oral de temazepam |
CA2716367C (en) | 2008-02-20 | 2015-05-26 | The Curators Of The University Of Missouri | Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same |
CN104127368A (zh) | 2008-03-11 | 2014-11-05 | 武田药品工业株式会社 | 口腔崩解固体制剂 |
JP5399749B2 (ja) * | 2008-03-27 | 2014-01-29 | 沢井製薬株式会社 | プロトンポンプ阻害剤を含有する被覆微粒子 |
JP5296456B2 (ja) * | 2008-08-26 | 2013-09-25 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
US8900634B2 (en) | 2008-11-03 | 2014-12-02 | Nal Pharmaceuticals, Ltd. | Diethylstilbestrol dosage form and methods of treatment using thereof |
US8715715B2 (en) | 2008-11-03 | 2014-05-06 | Nal Pharmaceuticals Ltd. | Dosage form for insertion into the mouth |
CN102264222B (zh) | 2008-11-04 | 2014-12-10 | 威麦迪克有限责任公司 | 抗病毒补剂 |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
KR101565621B1 (ko) * | 2009-01-26 | 2015-11-03 | 신에쓰 가가꾸 고교 가부시끼가이샤 | 저치환도 히드록시프로필셀룰로오스 수분산액을 이용한 습식 조립 타정법 |
JP5503192B2 (ja) * | 2009-06-03 | 2014-05-28 | 大原薬品工業株式会社 | 生理活性物質含有粒子の製造方法 |
CA2765033C (en) | 2009-06-12 | 2020-07-14 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
US20110318411A1 (en) | 2010-06-24 | 2011-12-29 | Luber Joseph R | Multi-layered orally disintegrating tablet and the manufacture thereof |
US20110070301A1 (en) | 2009-09-24 | 2011-03-24 | Luber Joseph R | Orally transformable tablets |
US8313768B2 (en) | 2009-09-24 | 2012-11-20 | Mcneil-Ppc, Inc. | Manufacture of tablet having immediate release region and sustained release region |
KR101573889B1 (ko) | 2009-10-09 | 2015-12-04 | 영진약품공업주식회사 | 속효성과 지속성을 동시에 갖는 약제학적 조성물 |
EP2319504A1 (en) * | 2009-11-07 | 2011-05-11 | Laboratorios Del. Dr. Esteve, S.A. | Pharmaceutical solid dosage form |
KR101765357B1 (ko) | 2009-12-02 | 2017-08-04 | 아데어 파마수티컬스 에스.알.엘. | 펙소페나딘 마이크로캡슐 및 그것을 함유하는 조성물 |
WO2011080502A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
US20120294937A1 (en) | 2009-12-29 | 2012-11-22 | Novartis Ag | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
US20110212171A1 (en) * | 2010-01-08 | 2011-09-01 | Eurand, Inc. | Taste masked topiramate composition and an orally disintegrating tablet comprising the same |
GB201003731D0 (en) | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Immediate/delayed drug delivery |
GB201003734D0 (en) * | 2010-03-05 | 2010-04-21 | Univ Strathclyde | Delayed prolonged drug delivery |
WO2011111027A2 (en) | 2010-03-11 | 2011-09-15 | Dexcel Pharma Technologies Ltd. | Oral dispersible delayed release tablet formulation |
US20130202688A1 (en) | 2010-05-04 | 2013-08-08 | Sunilendu Bhushan Roy | Delayed release oral disintegrating pharmaceutical compositions of lansoprazole |
US20110300216A1 (en) * | 2010-06-03 | 2011-12-08 | First Eric R | Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives |
NZ605562A (en) * | 2010-07-09 | 2013-11-29 | Teijin Pharma Ltd | Deuterated benzylbenzene derivatives and methods of use |
US20130115287A1 (en) * | 2010-07-09 | 2013-05-09 | Teijin Pharma Limited | Intraorally disintegrating tablet |
JP2012051832A (ja) * | 2010-08-31 | 2012-03-15 | Fancl Corp | 顆粒組成物及びそれを含有する食品又は医薬品 |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
JP2011046750A (ja) * | 2010-12-09 | 2011-03-10 | Mitsubishi Tanabe Pharma Corp | 口腔内速崩壊性錠 |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
EP2468263A1 (en) * | 2010-12-23 | 2012-06-27 | Laboratorios Del. Dr. Esteve, S.A. | Compressed solid dosage forms |
UY33841A (es) | 2010-12-27 | 2012-07-31 | Takeda Pharmaceutical | Comprimido de desintegracion oral |
US8426461B2 (en) | 2011-01-17 | 2013-04-23 | Takeda Pharmaceutical Company Limited | Orally dispersible tablet |
TW201309347A (zh) | 2011-01-17 | 2013-03-01 | Takeda Pharmaceutical | 口腔內崩散錠 |
JP5725884B2 (ja) * | 2011-01-27 | 2015-05-27 | 理研ビタミン株式会社 | 経口用製剤 |
AU2012214553B2 (en) | 2011-02-11 | 2015-07-09 | Sociétés des Produits Nestlé S.A. | Multiparticulate L-menthol formulations and related methods |
US8911780B2 (en) | 2011-02-11 | 2014-12-16 | Zx Pharma, Llc | Multiparticulate L-menthol formulations and related methods |
US8808736B2 (en) | 2011-02-11 | 2014-08-19 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
EP2687233A4 (en) | 2011-03-17 | 2014-11-19 | Kyowa Chem Ind Co Ltd | BINDER FOR FORMING TABLETS |
JP6003890B2 (ja) * | 2011-06-10 | 2016-10-05 | ニプロ株式会社 | 口腔内崩壊錠の製造方法 |
MY186477A (en) | 2011-11-30 | 2021-07-22 | Takeda Pharmaceuticals Co | Dry coated tablet |
US9511028B2 (en) | 2012-05-01 | 2016-12-06 | Johnson & Johnson Consumer Inc. | Orally disintegrating tablet |
US9445971B2 (en) | 2012-05-01 | 2016-09-20 | Johnson & Johnson Consumer Inc. | Method of manufacturing solid dosage form |
US9233491B2 (en) | 2012-05-01 | 2016-01-12 | Johnson & Johnson Consumer Inc. | Machine for production of solid dosage forms |
TW201400146A (zh) | 2012-06-05 | 2014-01-01 | Takeda Pharmaceutical | 有核錠 |
CN102805737A (zh) * | 2012-09-03 | 2012-12-05 | 海南中化联合制药工业股份有限公司 | 一种兰索拉唑肠溶口崩片及其制备方法 |
CN104968335A (zh) * | 2013-01-07 | 2015-10-07 | 三亚制药(株) | 具有改善的溶解度的新型快速溶解颗粒制剂 |
US9850512B2 (en) | 2013-03-15 | 2017-12-26 | The Research Foundation For The State University Of New York | Hydrolysis of cellulosic fines in primary clarified sludge of paper mills and the addition of a surfactant to increase the yield |
JP6258920B2 (ja) * | 2013-03-27 | 2018-01-10 | Meiji Seikaファルマ株式会社 | 口腔内崩壊性フィルムコーティング錠 |
PT2872123T (pt) | 2013-04-23 | 2017-03-15 | Zx Pharma Llc | Composição multiparticulada com revestimento entérico de libertação controlada de óleo de hortelã-pimenta e métodos relacionados |
EP2995299B1 (en) | 2013-05-08 | 2021-04-07 | Zensei Pharmaceutical Industries Co., Ltd. | Functional polymer film-coated particle having high drug content, tablet containing same, and methods for production thereof |
WO2014189034A1 (ja) | 2013-05-21 | 2014-11-27 | 武田薬品工業株式会社 | 口腔内崩壊錠 |
JP5714652B2 (ja) * | 2013-06-13 | 2015-05-07 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
MX368159B (es) | 2014-01-10 | 2019-09-20 | Johnson & Johnson Consumer Inc | Proceso para elaborar tabletas con el uso de radiofrecuencia y partículas disipativas revestidas. |
WO2015119289A1 (ja) * | 2014-02-10 | 2015-08-13 | 富士フイルム株式会社 | 口腔内崩壊錠 |
US9951363B2 (en) | 2014-03-14 | 2018-04-24 | The Research Foundation for the State University of New York College of Environmental Science and Forestry | Enzymatic hydrolysis of old corrugated cardboard (OCC) fines from recycled linerboard mill waste rejects |
US11813361B2 (en) | 2014-04-04 | 2023-11-14 | Pharmaquest International Center, Llp | Disintegrating monolithic modified release tablets containing quadri-layer extended release granules |
US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
US20170246187A1 (en) | 2014-08-28 | 2017-08-31 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
CA2962959C (en) * | 2014-10-08 | 2023-04-04 | Synthetic Biologics, Inc. | Beta-lactamase formulations and uses thereof |
GB201420306D0 (en) | 2014-11-14 | 2014-12-31 | Bio Images Drug Delivery Ltd | Compositions |
JP6670113B2 (ja) * | 2015-01-20 | 2020-03-18 | 日本ケミファ株式会社 | ロスバスタチンカルシウム製剤及びレーザー照射によるフィルムコーティング錠の印字方法 |
US9744135B2 (en) | 2015-02-27 | 2017-08-29 | Deseret Laboratories, Inc. | Fast disintegrating compositions and tablets thereof |
JP5978335B2 (ja) * | 2015-03-11 | 2016-08-24 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
WO2016154313A1 (en) * | 2015-03-24 | 2016-09-29 | Zywie, Llc | High drug loading liquid oral pharmaceutical compositions |
BR112017020790A2 (pt) * | 2015-03-31 | 2018-06-26 | Laboratorios Bagó S.A. | procedimento para preparação de pelotas com revestimento entérico contendo um inibidor de bomba de prótons e composições farmacêuticas em multipartículas que contêm as mesmas |
WO2016174664A1 (en) | 2015-04-29 | 2016-11-03 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
CN108136035A (zh) * | 2015-09-04 | 2018-06-08 | 株式会社大赛璐 | 超速崩解片剂及其制备方法 |
US10736855B2 (en) | 2016-02-25 | 2020-08-11 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
JP6151413B2 (ja) * | 2016-07-25 | 2017-06-21 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
WO2018098501A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
JP6866136B2 (ja) * | 2016-11-30 | 2021-04-28 | 共和薬品工業株式会社 | デュロキセチン塩酸塩を含む口腔内崩壊錠 |
JP7064683B2 (ja) * | 2017-01-27 | 2022-05-11 | 日本ケミファ株式会社 | 腸溶層破損防止用組成物 |
US10493026B2 (en) | 2017-03-20 | 2019-12-03 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
JP2017141299A (ja) * | 2017-05-24 | 2017-08-17 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
RU2020100230A (ru) | 2017-06-12 | 2021-07-13 | Глитек Ллс. | Лечение депрессии антагонистами nmda и антагонистами d2/5-ht2a или селективными антагонистами 5-нт2a |
WO2019039420A1 (ja) | 2017-08-21 | 2019-02-28 | ニプロ株式会社 | 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法 |
CN108576205B (zh) * | 2018-03-22 | 2022-01-04 | 湖北省农业科学院农产品加工与核农技术研究所 | 一种草莓联合干燥的处理方法 |
JP2018168185A (ja) * | 2018-07-05 | 2018-11-01 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
DE102019201445A1 (de) | 2019-02-05 | 2020-08-06 | Kniele Gmbh | Schräglagenmischer |
US11779541B2 (en) * | 2019-03-26 | 2023-10-10 | Johnson & Johnson Consumer Inc. | Immediate release dosage form |
JP2019203031A (ja) * | 2019-09-06 | 2019-11-28 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
JP7404828B2 (ja) | 2019-11-29 | 2023-12-26 | ニプロ株式会社 | 経口医薬製剤およびその製造方法 |
WO2021153525A1 (ja) * | 2020-01-27 | 2021-08-05 | 東和薬品株式会社 | エソメプラゾール経口製剤およびその製造方法 |
IL297776A (en) | 2020-04-30 | 2022-12-01 | Nanocopoeia Llc | Orally disintegrating tablets containing an amorphous solid dispersion of nalotinib |
EP4356902A1 (en) | 2022-10-19 | 2024-04-24 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A capsule comprising lansoprazole |
EP4356903A1 (en) | 2022-10-19 | 2024-04-24 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Microtablets comprising lansoprazole |
EP4356905A1 (en) | 2022-10-19 | 2024-04-24 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Tablets-in-capsule comprising lansoprazole |
EP4356904A1 (en) | 2022-10-19 | 2024-04-24 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A capsule comprising lansoprazole |
KR102553713B1 (ko) * | 2022-11-18 | 2023-07-10 | 고덕상 | 미네랄 촉매제를 이용한 양식어류사료 제조방법 |
Family Cites Families (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE416649B (sv) | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
JPS5163927A (en) | 1974-11-28 | 1976-06-02 | Shinetsu Chemical Co | Ketsugoseiryokonajozaihokaizaino seizohoho |
GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
JPS5411226A (en) | 1977-06-24 | 1979-01-27 | Shin Etsu Chem Co Ltd | Disintegratable granule |
SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
JPS5614098A (en) | 1979-07-13 | 1981-02-10 | Takeda Chem Ind Ltd | Externally lubricating tablet making machine |
US4359465A (en) | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
ZA828136B (en) | 1981-11-05 | 1983-09-28 | Byk Gulden Lomberg Chem Fab | Substituted benzimidazoles,a process for their preparation,their use,and medicaments containing them |
SE8300736D0 (sv) | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
SE8404808L (sv) * | 1983-10-03 | 1985-04-04 | Avner Rotman | Mikrokapslat lekemedel i sot matris |
US4749575A (en) * | 1983-10-03 | 1988-06-07 | Bio-Dar Ltd. | Microencapsulated medicament in sweet matrix |
IL75400A (en) | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
JPS6150978A (ja) | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
IT1177384B (it) * | 1984-12-12 | 1987-08-26 | Boeehringer Biochemia Robin Sp | Prodotti dietetici granulari a base di amminoacidi e procedimento per la loro preparazione |
JPH072761B2 (ja) | 1985-03-20 | 1995-01-18 | 不二パウダル株式会社 | 微結晶セルロ−ス球形顆粒及びその製造法 |
US4738975A (en) | 1985-07-02 | 1988-04-19 | Takeda Chemical Industries, Ltd. | Pyridine derivatives, and use as anti-ulcer agents |
GB8518301D0 (en) * | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
SE450087B (sv) | 1985-10-11 | 1987-06-09 | Haessle Ab | Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial |
JPS62111980A (ja) | 1985-11-08 | 1987-05-22 | Otsuka Pharmaceut Co Ltd | 1h−ベンズイミダゾ−ル誘導体 |
GB8530365D0 (en) * | 1985-12-10 | 1986-01-22 | Univ Bath | Manufacture of moulded products |
US5433959A (en) * | 1986-02-13 | 1995-07-18 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
CA1327010C (en) | 1986-02-13 | 1994-02-15 | Tadashi Makino | Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production |
JPS62277322A (ja) | 1986-02-13 | 1987-12-02 | Takeda Chem Ind Ltd | 安定化された腸溶性抗潰瘍固形組成物 |
GB2189699A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
GB2189698A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
US4710384A (en) | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
US4830853A (en) * | 1986-10-20 | 1989-05-16 | Warner-Lambert Company | Drug compositions stabilized against oxidation |
JPH0674272B2 (ja) | 1986-11-13 | 1994-09-21 | エーザイ株式会社 | ピリジン誘導体及びそれを含有する潰瘍治療剤 |
JPH0832625B2 (ja) | 1987-01-29 | 1996-03-29 | 武田薬品工業株式会社 | 有核顆粒およびその製造法 |
US5026560A (en) | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
JP2718945B2 (ja) | 1987-06-17 | 1998-02-25 | エーザイ株式会社 | ピリジン誘導体及びそれを含有する潰瘍治療剤 |
US5030447A (en) | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
JPH0723304B2 (ja) | 1988-04-19 | 1995-03-15 | 三菱化学株式会社 | 薬剤成分固定化組成物 |
JPH0720858B2 (ja) | 1988-04-19 | 1995-03-08 | 三菱化学株式会社 | 被覆固形薬剤 |
US4910023A (en) | 1988-06-09 | 1990-03-20 | Warner-Lambert Company | Drug in combination with flavor masking agent and method for making same |
CA1338596C (en) * | 1988-09-27 | 1996-09-17 | Hiroyoshi Koyama | Granules having core and their production |
GB8824392D0 (en) | 1988-10-18 | 1988-11-23 | Ciba Geigy Ag | Dispersible formulation |
US4936074A (en) * | 1988-11-17 | 1990-06-26 | D. M. Graham Laboratories, Inc. | Process for preparing solid encapsulated medicament |
US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
IT1238072B (it) | 1990-01-19 | 1993-07-03 | Sclavo Spa | Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina |
EP0452862B1 (en) | 1990-04-18 | 1995-07-19 | Asahi Kasei Kogyo Kabushiki Kaisha | Spherical seed cores, spherical granules and process for production thereof |
JPH0466538A (ja) | 1990-07-04 | 1992-03-02 | Suntory Ltd | 抗潰瘍剤 |
JP3163382B2 (ja) | 1990-10-17 | 2001-05-08 | 武田薬品工業株式会社 | ピリジン誘導体およびその製造法 |
US5316772A (en) | 1990-12-19 | 1994-05-31 | Solvay & Cie, S.A. (Societe Anonyme) | Bilayered oral pharmaceutical composition with pH dependent release |
JP2820829B2 (ja) | 1991-03-07 | 1998-11-05 | 武田薬品工業株式会社 | 有核散剤およびその製造方法 |
YU48263B (sh) | 1991-06-17 | 1997-09-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh. | Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola |
FR2679451B1 (fr) | 1991-07-22 | 1994-09-09 | Prographarm Laboratoires | Comprime multiparticulaire a delitement rapide. |
US5464632C1 (en) | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
JPH05117268A (ja) | 1991-10-22 | 1993-05-14 | Yoshitomi Pharmaceut Ind Ltd | ピリジン化合物 |
ATE216577T1 (de) * | 1992-01-29 | 2002-05-15 | Takeda Chemical Industries Ltd | Schnellösliche tablette und ihre herstellung |
JPH05310558A (ja) | 1992-05-07 | 1993-11-22 | Lion Corp | 固形製剤組成物 |
JP3059004B2 (ja) | 1992-09-18 | 2000-07-04 | ダイセル化学工業株式会社 | アルカリ水溶液に対する溶解性の高い低置換度ヒドロキシプロピルセルロース及びその製造法 |
JPH06305962A (ja) | 1993-04-21 | 1994-11-01 | Taisho Pharmaceut Co Ltd | アトピー性皮膚炎治療剤 |
JP3502951B2 (ja) | 1993-07-06 | 2004-03-02 | 大正製薬株式会社 | 高脂血症治療剤 |
IL110376A (en) | 1993-08-02 | 1998-08-16 | Bristol Myers Squibb Co | Pharmaceutical preparations containing iftroban and methods for their preparation |
US5935600A (en) * | 1993-09-10 | 1999-08-10 | Fuisz Technologies Ltd. | Process for forming chewable quickly dispersing comestible unit and product therefrom |
US5965162A (en) * | 1993-09-10 | 1999-10-12 | Fuisz Technologies Ltd. | Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom |
DK0723777T3 (da) * | 1993-10-12 | 2002-10-28 | Mitsubishi Pharma Corp | Tablet indeholdende enteriske granuler |
JP2681601B2 (ja) | 1993-11-01 | 1997-11-26 | 協和醗酵工業株式会社 | 外部滑沢式打錠機 |
US5549911A (en) | 1994-01-14 | 1996-08-27 | Laboratoires Des Produits Ethiques Ethypharm | Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract |
MX9603035A (es) | 1994-01-31 | 1997-05-31 | Yamanouchi Pharma Co Ltd | Moldeos comprimidos que se disuelven intrabucalmente y proceso para su produccion. |
US5576014A (en) * | 1994-01-31 | 1996-11-19 | Yamanouchi Pharmaceutical Co., Ltd | Intrabuccally dissolving compressed moldings and production process thereof |
IL112779A (en) * | 1994-03-01 | 1999-11-30 | Gergely Gerhard | Granular product or tablet containing an efferescent system and an active pharmaceutical substance and its preparation |
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
HUT75775A (en) * | 1994-07-08 | 1997-05-28 | Astra Ab | Medicament with multiple unit tablated dosage form containing omeprazole |
JPH0827033A (ja) | 1994-07-14 | 1996-01-30 | Nikken Chem Co Ltd | エリスリトール含有固形剤 |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
JP2919771B2 (ja) | 1995-04-17 | 1999-07-19 | 佐藤製薬株式会社 | 速溶解性錠剤の製造方法及び該製造方法により製造した速溶解性錠剤 |
US5656284A (en) * | 1995-04-24 | 1997-08-12 | Balkin; Michael S. | Oral transmucosal delivery tablet and method of making it |
SE9501881D0 (sv) | 1995-05-19 | 1995-05-19 | Astra Ab | New pharmacological use of AII-receptor antagonists |
JPH08310969A (ja) | 1995-05-22 | 1996-11-26 | Lion Corp | 固形薬品組成物及びその製造方法 |
US5658583A (en) | 1995-07-28 | 1997-08-19 | Zhang; Jie | Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals |
JPH0948726A (ja) | 1995-08-07 | 1997-02-18 | Tanabe Seiyaku Co Ltd | 口腔内速崩壊性製剤およびその製法 |
JPH0971523A (ja) | 1995-09-07 | 1997-03-18 | Riyuukakusan:Kk | 口腔内で崩壊性の速い錠剤 |
US5824339A (en) * | 1995-09-08 | 1998-10-20 | Takeda Chemical Industries, Ltd | Effervescent composition and its production |
SE9600071D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
SE512835C2 (sv) * | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
SE9600072D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
US5840332A (en) | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
CA2248179C (en) | 1996-02-29 | 2007-09-18 | Fujisawa Pharmaceutical Co., Ltd. | .beta.-lactam antibiotic-containing tablet and production thereof |
EP0799616A1 (en) * | 1996-04-01 | 1997-10-08 | Takeda Chemical Industries, Ltd. | Oral composition comprising a fumagillol derivative |
US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
ATE297191T1 (de) | 1996-06-14 | 2005-06-15 | Kyowa Hakko Kogyo Kk | Im munde schnellzerfallende tablette |
GB9613470D0 (en) * | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
CN1222317C (zh) | 1996-07-12 | 2005-10-12 | 第一制药株式会社 | 可迅速崩解的压模物质及其生产方法 |
EP0839526A3 (en) | 1996-10-31 | 1999-01-07 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation with fast buccal disintegration or dissolution |
ES2364145T3 (es) | 1996-11-15 | 2011-08-25 | Ajinomoto Co., Inc. | Composición de nateglinida en comprimidos. |
CA2281473C (en) * | 1997-02-20 | 2007-01-16 | Therics, Inc. | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
TW580397B (en) * | 1997-05-27 | 2004-03-21 | Takeda Chemical Industries Ltd | Solid preparation |
US5968453A (en) * | 1997-07-17 | 1999-10-19 | Carolina Liquid Chemistries Corporation | Reagent cartridge |
US5869098A (en) * | 1997-08-20 | 1999-02-09 | Fuisz Technologies Ltd. | Fast-dissolving comestible units formed under high-speed/high-pressure conditions |
EP2263660B1 (en) * | 1998-05-18 | 2017-09-27 | Takeda Pharmaceutical Company Limited | Orally disintegrable tablets |
US20060182802A1 (en) | 1998-07-28 | 2006-08-17 | Toshihiro Shimizu | Rapidly disintegrable solid preparation |
US6531152B1 (en) | 1998-09-30 | 2003-03-11 | Dexcel Pharma Technologies Ltd. | Immediate release gastrointestinal drug delivery system |
JP4066538B2 (ja) | 1998-11-06 | 2008-03-26 | 株式会社大林組 | 廃棄物処分場 |
JP3452862B2 (ja) | 2000-03-21 | 2003-10-06 | 株式会社野島角清製作所 | 雨樋受具 |
-
1999
- 1999-05-17 EP EP10177471.9A patent/EP2263660B1/en not_active Expired - Lifetime
- 1999-05-17 CN CNB998055115A patent/CN1195500C/zh not_active Expired - Lifetime
- 1999-05-17 DE DE69934505T patent/DE69934505T2/de not_active Expired - Lifetime
- 1999-05-17 ES ES06076634.2T patent/ES2559766T3/es not_active Expired - Lifetime
- 1999-05-17 CA CA002587022A patent/CA2587022A1/en not_active Abandoned
- 1999-05-17 US US09/355,781 patent/US6328994B1/en not_active Expired - Lifetime
- 1999-05-17 PT PT101774719T patent/PT2263660T/pt unknown
- 1999-05-17 DK DK06076634.2T patent/DK1736144T3/en active
- 1999-05-17 PT PT60766342T patent/PT1736144E/pt unknown
- 1999-05-17 JP JP13517799A patent/JP3746167B2/ja not_active Expired - Fee Related
- 1999-05-17 EP EP06076634.2A patent/EP1736144B1/en not_active Expired - Lifetime
- 1999-05-17 AU AU37316/99A patent/AU3731699A/en not_active Abandoned
- 1999-05-17 DK DK99919614T patent/DK1121103T3/da active
- 1999-05-17 AT AT99919614T patent/ATE348601T1/de active
- 1999-05-17 WO PCT/JP1999/002548 patent/WO1999059544A2/en active IP Right Grant
- 1999-05-17 KR KR1020007011763A patent/KR100554924B1/ko not_active IP Right Cessation
- 1999-05-17 KR KR1020047021546A patent/KR101032289B1/ko not_active IP Right Cessation
- 1999-05-17 ES ES99919614T patent/ES2274625T3/es not_active Expired - Lifetime
- 1999-05-17 DK DK10177471.9T patent/DK2263660T3/en active
- 1999-05-17 EP EP99919614A patent/EP1121103B1/en not_active Revoked
- 1999-05-17 PT PT99919614T patent/PT1121103E/pt unknown
- 1999-05-17 CA CA002323680A patent/CA2323680C/en not_active Expired - Lifetime
- 1999-05-18 TW TW088108021A patent/TWI243062B/zh not_active IP Right Cessation
-
2000
- 2000-05-12 JP JP2000139587A patent/JP4454791B2/ja not_active Expired - Lifetime
-
2001
- 2001-09-22 HK HK01106717A patent/HK1036401A1/xx not_active IP Right Cessation
- 2001-09-22 HK HK07102071.1A patent/HK1096021A1/zh not_active IP Right Cessation
- 2001-10-30 US US10/017,755 patent/US7431942B2/en not_active Expired - Fee Related
-
2007
- 2007-01-08 CY CY20071100020T patent/CY1105908T1/el unknown
-
2008
- 2008-05-07 US US12/151,572 patent/US7875292B2/en not_active Expired - Fee Related
-
2010
- 2010-12-14 US US12/967,858 patent/US20110081412A1/en not_active Abandoned
-
2014
- 2014-05-27 US US14/287,740 patent/US9901546B2/en not_active Expired - Fee Related
-
2016
- 2016-01-28 CY CY20161100080T patent/CY1119153T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1036401A1 (en) | Orally disintegrable tablets comprising a benzimidazole | |
KR100780156B1 (ko) | 맛 차폐용 코팅 조성물 | |
EP1276470B1 (en) | Taste masking coating composition | |
CA2238271A1 (en) | Pharmaceutical compositions comprising flurbiprofen | |
HUP0103388A2 (hu) | Orális, folyékony mukoadhezív készítmények | |
ZA200205512B (en) | Novel substituted benzimidazole dosage forms and methods of using same. | |
RU98111594A (ru) | Фармацевтические композиции, включающие флурбипрофен | |
CA2348451A1 (en) | Dosage forms containing taste masked active agents | |
GB9509764D0 (en) | Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids | |
WO2002045684A3 (en) | Rapidly dispersing pharmaceutical composition comprising effervescent agents | |
ATE227978T1 (de) | Orale flüssige mucoadhäsive zusammensetzungen | |
EP1123696A4 (en) | COMPOSITIONS FOR ORAL CAVITY | |
CA2136404A1 (fr) | Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale | |
MY129314A (en) | Pharmaceutical composition comprising sumatriptan | |
JP3170855B2 (ja) | イブプロフェン含有解熱鎮痛剤 | |
AP1485A (en) | Orally administered controlled delivery system for once daily administration of ciprofloxacin. | |
JP2000063268A (ja) | 口腔粘膜付着型徐放性錠剤及び歯周疾患治療剤 | |
HUP0103685A2 (hu) | Orális, folyékony mukoadhezív készítmények | |
WO2004032843A3 (en) | Mucoadhesive tetracycline formulations | |
AU2001295839A1 (en) | Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa | |
UY26605A1 (es) | Sistema de administración oral controlada para la ingestión diaria de ciprofloxacina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHRG | Changes in the register | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20150517 |